Galeterone

N/A

Report date: 2025/11/17 10:07:50
NME

Base Information

Drug NameGaleterone
Drug Alias Name伽来特隆galeteronum加来特龙galeteronaVN/124-1 +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor antagonistsSteroid 17-alpha-hydroxylase inhibitors
TargetsAndrogen ReceptorSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsProstatic NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTokai
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore
Inactive CompaniesLTN Pharmaceuticals Inc
Active IndicationsPancreatic Neoplasms
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG